Special

Fixed-duration therapies for CLL

J. Collins, T. Feys

Medical need for patients with resistance to covalent Bruton tyrosine kinase inhibitors

A. Enguita, T. Feys

Expanding the therapeutic armamentarium in relapsed/refractory Diffuse Large B-cell Lymphoma

J. Blokken, T. Feys

Towards a chemotherapy-free future for patients with follicular lymphoma

J. Collins, T. Feys

SPECIALS

PHARMA NEWS